Traders Bet on Abbott Laboratories Joining Healthcare Slide

ABT recently bounced from the 160-day moving average

May 11, 2018 at 11:14 AM
facebook X logo linkedin

President Donald Trump is expected to announce a plan to lower drug prices today, which should put healthcare sector in focus on Wall Street. This group has struggled in 2018, illustrated by a recent email sent out by Schaeffer's Quantitative Analyst Chris Prybal showing the extreme underperformance of the 20 names that we cover in our "Pharmaceuticals and Biotechnology" category.

Prybal notes that this group's collective market cap has seen the biggest decrease in 2018 by far out of all the sectors we track, with only four of the 20 companies seeing their market caps climb year-to-date. One pharmaceutical stock that's managed to hold gains so far in 2018 is Abbott Laboratories (NYSE:ABT), but data shows bears are moving in.

ABT stock was last seen trading up 0.6% at $60.92, pacing for a third straight win and its highest close since March 26. The shares took a sharp bounce off their 160-day moving average earlier this month, and have since pushed through recent resistance at the $60 level. Overall, the healthcare giant is up 6.7% year-to-date.

abt stock price

Analysts are extremely bullish on Abbott, with 17 of the 20 brokerage firms in coverage saying to buy the shares. Plus, the average 12-month price target is $68.56, representing a 12.7% premium to current levels and record-high territory. Looking elsewhere, however, shows increasing negativity around the stock.

In fact, short interest has been surging on the stock, rising almost 53% in the last reporting period alone -- one of the biggest increases among all stocks that trade more than one million shares per day or trade weekly options. At the same time, less than 1% of the total float is sold short.

But options traders have also been showing bearish tendencies. ABT's 10-day put/call volume ratio across the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) stands at 1.10, ranking in the 83rd annual percentile. This suggests put buying has been unusually popular in recent weeks, relative to call buying.


Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI